title: Bevacizumab for retinopathy of prematurity.
authors.forename: Glen A
authors.initials: GA
authors.lastname: Gole
authors.forename: Jayne E
authors.initials: JE
authors.lastname: Camuglia
authors.forename: Anna L
authors.initials: AL
authors.lastname: Ells
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D053685:Laser Therapy; D012107:Research Design; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000628:therapy
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab